Most Read Articles
2 days ago
During the Allergic Rhinitis (AR) Boot Camp held in conjunction with the Bayer Pharmacist Congress 2020, Professor Dr Baharudin Abdullah discussed the management of AR in the primary care setting and the importance of using patient profiles to guide the choice of antihistamines.
Pank Jit Sin, 14 Apr 2020
With the movement control order (MCO) in full gear, most conferences and meetings are being postponed or cancelled. Some have taken to having conferences and meetings in a virtual setting, such as the recently ended American College of Cardiology/World Congress of Cardiology (ACC.20/WCC) conference. MIMS and the Asian Young Pharmacist Group (AYPG) took this opportunity to engage with pharmacists in the form of a Zoom meeting. 
Pearl Toh, 05 Aug 2020
The direct oral anticoagulant apixaban may help prevent deaths when given at prophylactic or therapeutic doses in hospitalized COVID-19 patients with elevated D-dimer levels, according to an analysis presented during the ISTH 2020 Congress.

Steroids, NSAIDs after laser trabeculoplasty reduce IOP

28 Oct 2019
Remind customers to use eye treatments for a month only, as, after that, they become ineffective

Eyes treated with steroid or nonsteroidal anti-inflammatory drug (NSAID) drops after selective laser trabeculoplasty (SLT) show significantly better reduction in intraocular pressure (IOP) at 12 weeks, a study has shown.

Patients aged >18 years with IOP of >18 mm Hg for whom the clinician decided SLT was the appropriate therapy were included in this double-masked, randomized, placebo-controlled, dual-centre, multisurgeon trial. They were randomly allocated to one of three groups: ketorolac 0.5%, prednisolone 1% or saline tears.

Participants were instructed to use an unmarked drop 4 times daily starting the day of SLT and continuing for 4 more days. The investigators used the Kruskal-Wallis test and Wilcoxon rank-sum test for continuous variables when comparing two or three treatment groups, respectively.  For categorical variables, the Fisher exact test was used.

Ninety-six eyes of 85 patients were included in the trial. All three groups had similar baseline demographics and baseline IOP (mean, 23.3±3.9 mm Hg; p=0.57).

At week 6, no statistically significant difference in IOP decrease was observed among the NSAID, steroid and placebo groups. At week 12, a statistically greater decrease in IOP was found in the NSAID and steroid groups compared with the placebo group (mean, –6.2±3.1 mm Hg, –5.2±2.7 mm Hg and –3±4.3 mm Hg, respectively; NSAID vs placebo: p=0.02 [analysis of variance] and p=0.002 [t test]; steroid vs placebo: p=0.02).

“Short-term postoperative use of NSAID or steroid drops may improve IOP reduction after SLT,” the investigators said. “Longer-term follow-up studies are indicated.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
During the Allergic Rhinitis (AR) Boot Camp held in conjunction with the Bayer Pharmacist Congress 2020, Professor Dr Baharudin Abdullah discussed the management of AR in the primary care setting and the importance of using patient profiles to guide the choice of antihistamines.
Pank Jit Sin, 14 Apr 2020
With the movement control order (MCO) in full gear, most conferences and meetings are being postponed or cancelled. Some have taken to having conferences and meetings in a virtual setting, such as the recently ended American College of Cardiology/World Congress of Cardiology (ACC.20/WCC) conference. MIMS and the Asian Young Pharmacist Group (AYPG) took this opportunity to engage with pharmacists in the form of a Zoom meeting. 
Pearl Toh, 05 Aug 2020
The direct oral anticoagulant apixaban may help prevent deaths when given at prophylactic or therapeutic doses in hospitalized COVID-19 patients with elevated D-dimer levels, according to an analysis presented during the ISTH 2020 Congress.